PMC9756026_01
Comparison of 2 colonoscopies of patient 1. (A) February 1, 2020; (B) March 3, 2020
AnnGastroenterol-36-97-g002.jpg
PMC9756026_01_AnnGastroenterol-36-97-g002.jpg
F1
He underwent colonoscopy (Fig. 1A) and was administered tofacitinib after steroid resistance was observed. He was discharged from the hospital after clinical remission on March 3, 2020 (Fig. 1B).
PMC9756026_02
PMC9756026_03
Comparison of 2 colonoscopies of patient 3. (A) October 24, 2018; (B) December 14, 2018
AnnGastroenterol-36-97-g003.jpg
PMC9756026_03_AnnGastroenterol-36-97-g003.jpg
F2
She underwent colonoscopy (Fig. 2A) and was administered tofacitinib after steroid resistance was observed. She was discharged from the hospital after clinical remission on December 14, 2018 (Fig. 2B).
PMC9756026_04
Comparison of 2 colonoscopies of patient 4. (A) August 1, 2019; (B) September 18, 2019
AnnGastroenterol-36-97-g004.jpg
PMC9756026_04_AnnGastroenterol-36-97-g004.jpg
F3
She underwent colonoscopy (Fig. 3A) and was administered tofacitinib after steroid resistance was observed. She was discharged from the hospital after clinical remission on September 18, 2019 (Fig. 3B).
PMC9756026_05
Comparison of 2 colonoscopies of patient 5. (A) August 1, 2019; (B) December 8, 2019
AnnGastroenterol-36-97-g005.jpg
PMC9756026_05_AnnGastroenterol-36-97-g005.jpg
F4
His UCDAI score and Mayo score were 12. He underwent colonoscopy (Fig. 4A) and was given tofacitinib after steroid resistance was observed. He was discharged from the hospital after clinical remission on December 8, 2019 (Fig. 4B).
PMC9756026_06
PMC9756026_07
PMC9756026_08
Comparison of 2 colonoscopies of patient 8. (A) January 30, 2021; (B) February 27, 2021
AnnGastroenterol-36-97-g006.jpg
PMC9756026_08_AnnGastroenterol-36-97-g006.jpg
F5
His UCDAI score and Mayo score were 12. He underwent colonoscopy (Fig. 5A) and was given tofacitinib after steroid resistance was observed. He was discharged from the hospital after clinical remission on February 27, 2021 (Fig. 5B).